A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1) A Phase 3 Randomized Non-Inferiority Study of Carboplatinand Vincristine Versus Selumetinib (NSC# 74 ...
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis a ...
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG) A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previ ...
Low Grade Glioma;Neurofibromatosis Type 1;Visual Pathway Glioma
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma Vinblastine and Carboplatinin Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Gl ...
A Phase I Study of Vinblastine in Combination With Carboplatin for Children With Newly Diagnosed and Recurrent Low-Grade Gliomas A Phase I Study of Vinblastine in Combination With Carboplatinfor Children With Newly Diagnosed and ...
Brain and Central Nervous System Tumors;Neurofibromatosis Type 1